Proper way to acknowledge SERCEB funding in your publications
For each publication that results from NIH grant-supported research, grantees must include an acknowledgment of NIH grant support and a disclaimer stating the following:
“This publication was made possible by NIH grant #U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense.”
“The project described was supported by NIH grant #U54 AI057157 from Southeastern Regional Center of Excellence for Emerging Infections and Biodefense.”
“Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.”
Dual Use Policy
The SERCEB Steering Committee adopted a policy on dual-use potential and concerns for on-going work, should an investigator, in the course of their research,
encounter the discovery of additional strains or mutant strains with the potential for increased risk of infectivity or overwhelming host responses. All SERCEB-funded investigators are asked to familiarize themselves with this policy.
Data Sharing Plan
Under the terms and conditions of our SERCEB renewal award (Section V.2.C of RFA-AI-08-002: Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research), all funded investigators are required to abide by a Data Sharing Plan. The SERCEB Data Sharing Plan was approved and adopted by the SERCEB Steering Committee on July 7, 2009.
SERCEB Diversity Statement
Diversity is an integral component of the activities of SERCEB. Embracing diverse backgrounds, different life experiences and perspectives, the investigators and their teams recognize and support these beneficial interactions. The RCE program, in general, and SERCEB in particular, identifies emerging infectious diseases as a global problem that by nature is multicultural and demands inclusiveness, equity and fairness. SERCEB is both committed to these efforts as well as dedicated to providing mentorship and leadership in this area.
SERCEB Biohazard Incident Reporting Policy
Research in emerging infections and biodefense is under significant public scrutiny. Significant events related to SERCEB-funded research must be reported promptly to the SERCEB director and appropriate steering committee member as outlined in the SERCEB Biohazard Incident Reporting Policy adopted by the SERCEB Steering Committee on March 22, 2011.